The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...
The extent to which PSA screening is related to prostate cancer mortality reduction in the United States (US) is controversial. US Surveillance, Epidemiology, and End Results Program (SEER) data from ...
To investigate the effect of both prostate volume and serum testosterone changes on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy. A total of ...
Reduction in prostate cancer-specific mortality corresponds to two fewer deaths per 1,000/ (HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results